U.S. Neurosurgical Holdings, Inc.
USNU
$0.83
-$0.005-0.60%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 134.20% | 115.50% | 66.28% | 33.01% | -28.14% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 134.20% | 115.50% | 66.28% | 33.01% | -28.14% |
Operating Income | -134.20% | -115.50% | -66.28% | -33.01% | 28.14% |
Income Before Tax | -172.18% | -687.18% | -184.07% | -0.17% | 46.60% |
Income Tax Expenses | -- | -540.54% | -528.95% | -517.95% | -- |
Earnings from Continuing Operations | -152.21% | -451.81% | -119.71% | 16.65% | 47.99% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -506.90% | -250.79% | -110.00% | -99.57% |
Net Income | -152.52% | -621.34% | -184.92% | 0.20% | 38.91% |
EBIT | -134.20% | -115.50% | -66.28% | -33.01% | 28.14% |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -24.56% | -298.16% | -82.48% | 18.48% | 44.62% |
Normalized Basic EPS | -44.35% | -527.92% | -4,380.00% | -60.99% | 16.30% |
EPS Diluted | -24.56% | -298.16% | -82.48% | 18.48% | 44.62% |
Normalized Diluted EPS | -44.35% | -527.92% | -4,380.00% | -60.99% | 16.30% |
Average Basic Shares Outstanding | 77.47% | 76.65% | 48.29% | 30.96% | 18.24% |
Average Diluted Shares Outstanding | 77.47% | 76.65% | 48.29% | 30.96% | 18.24% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |